CEDIA(R) THEOPHYLLINE ASSAY/MODIFICATION— 510(k) K905521
Substantially EquivalentMicrogenics Corp.
FDA 510(k) clearance K905521 for CEDIA(R) THEOPHYLLINE ASSAY/MODIFICATION, Substantially Equivalent on 1990-12-26. Applicant: Microgenics Corp.. Device class: 2.
Clearance details
- Applicant
- Microgenics Corp.
- Product code
- Code LER
- Device class
- Class 2
- Regulation
- 21 CFR 862.3880
- Advisory panel
- Clinical Toxicology
- Date received
- Decision date
- Decision
- Substantially Equivalent
- Clearance type
- Traditional
- Location
- Concord, CA, US
Recent devices under product code LER
view allMore clearances from Microgenics Corp.
view allData sourced from openFDA. This site is unofficial and independent of the FDA.